{"transactions":[{"id":1867469,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":112731,"kind":"person","name":"Obrocea Mihail","position":1,"cik":"0001913265","reported_name":"Obrocea Mihail","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2023-06-05T21:23:44.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":87495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":87495,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":87495},"source":{"system":"sec-edgar","filing":"0001127602-23-017885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223017885/form4.xml","form_type":"4"}},{"id":1959063,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":112731,"kind":"person","name":"Obrocea Mihail","position":1,"cik":"0001913265","reported_name":"Obrocea Mihail","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2023-03-10T22:06:34.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":100000,"derivative":{"exercise_price":4.1,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-23-009773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009773/form4.xml","form_type":"4"}},{"id":2154195,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":112731,"kind":"person","name":"Obrocea Mihail","position":1,"cik":"0001913265","reported_name":"Obrocea Mihail","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2022-09-20T15:13:27.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":100000,"derivative":{"exercise_price":3.56,"expiration_date":"2032-09-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-22-022737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222022737/form4.xml","form_type":"4"}},{"id":2197921,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":112731,"kind":"person","name":"Obrocea Mihail","position":1,"cik":"0001913265","reported_name":"Obrocea Mihail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-02T22:35:29.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":1000,"price":5,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":27100,"source":{"system":"sec-edgar","filing":"0000899243-22-027459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027459/doc4.xml","form_type":"4"}}]}